A decision aid has been developed at McMaster University in Canada that aims to assist patients with established Atrial Fibrillation in choosing among antithrombotic agents - antiplatelets (aspirin), warfarin, and four new direct-acting oral anticoagulants. A No treatment option is also included. We translate it into Annalisa format.